KRAS and cancer: A previous study (in the GSE39582 cohort) classified CRC into four subtypes according to dominant molecular and respective biological characteristics: “CIN”, “dMMR”, “KRASm” (for KRAS-mutant) and “CSC” (for cancer stem cells).